Gajuwaka Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2002.
2002 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Gajuwaka Pharmaceuticals Private Limited

Gajuwaka Pharmaceuticals Private Limited, a active private limited company, was established on 10 January 2002 in Visakhapatnam, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239AP2002PTC038342. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.88 M.

It upholds a compliant status. Its leadership includes Surya Narayana Murthy Kandregula (Director), Venkata Satyasubbarao Kethineedi (Director), Narasimharaju Datlavenkata (Director). Past directors included Surya Narayana Murthy Kandregula, Venkata Satyasubbarao Kethineedi, Narasimharaju Datlavenkata. It holds ₹4.00 M open charges and ₹8.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #9-7-211/4, Shankar Nagar, 3Rd Lane, Beside Lakshmikanth Theatre, Gajuwaka, Visakhapatnam, Andhra Pradesh, 530026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239AP2002PTC038342

  • Registration Number

    038342

  • Incorporation Date

    10 January 2002

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.88 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.88 M
  • Company Age 24 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 M
  • Satisfied Charges ₹ 8.50 M
  • Revenue Growth **** -13.17%
  • Profit Growth **** -1.34%
  • Ebitda **** 3.30%
  • Net Worth 118.65%
  • Total Assets **** 2.07%
Company report

Gajuwaka Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gajuwaka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gajuwaka Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Surya Narayana Murthy Kandregula Director 14 Mar 2014 Current
Venkata Satyasubbarao Kethineedi Director 14 Mar 2014 Current
Narasimharaju Datlavenkata Director 14 Mar 2014 Current
Papa Rao Vegi Managing Director 14 Mar 2014 Current
Adi Ganeswararao Konathala Director 19 Mar 2018 Current
Narayana Murthy Kandregula Director 19 Mar 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Managing Director 14 Mar 2014 Past
Pramod Abcsdd Director 14 Mar 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gajuwaka Pharmaceuticals.

Gajuwaka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.17% decrease. The company also saw a slight decrease in profitability, with a 1.34% decrease in profit. The company's net worth Soared by an impressive increase of 118.65%.

Gajuwaka Pharmaceuticals revenue growth over time
Gajuwaka Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -13.17%
*******
*******
*******
*******
Revenue from Operations
*******
 -13.15%
*******
*******
*******
*******
Total Assets
*******
 2.07%
*******
*******
*******
*******
Profit or Loss
*******
 -1.34%
*******
*******
*******
*******
Net Worth
*******
 118.65%
*******
*******
*******
*******
EBITDA
*******
 3.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gajuwaka Pharmaceuticals?

Unlock access to Gajuwaka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000.00

Satisfied Charges

₹8,500,000.00

Charges Breakdown by Lending Institutions
  • The Karur Vysya Bank Limited : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2014 The Karur Vysya Bank Limited ₹4.00 M Open
30 Nov 2006 Indian Overseas Bank ₹3.50 M Satisfied
22 Sep 2005 State Bank Of India ₹2.50 M Satisfied
23 Mar 2004 Indian Overseas Bank ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Gajuwaka Pharmaceuticals?

Unlock and access historical data on people associated with Gajuwaka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gajuwaka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gajuwaka Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gajuwaka Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Gajuwaka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Gajuwaka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.

  • Director Appointment

    The activity Adi Ganeswararao Konathala was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 7 years 11 months . was completed.

  • Director Appointment

    Progress on Narayana Murthy Kandregula was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 7 years 11 months . was documented.

  • Charges

    A charge registered on 23 Mar 2004 via Charge ID 90119267 with Indian Overseas Bank was fully satisfied on 02 Jan 2018. was recorded as a recent event.

  • Charges

    The activity A charge registered on 30 Nov 2006 via Charge ID 10032987 with Indian Overseas Bank was fully satisfied on 08 Dec 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gajuwaka Pharmaceuticals Private Limited?

The CIN of Gajuwaka Pharmaceuticals Private Limited is U24239AP2002PTC038342.

Where is Gajuwaka Pharmaceuticals Private Limited headquartered?

Gajuwaka Pharmaceuticals Private Limited is headquartered at #9-7-211/4, Shankar Nagar, 3Rd Lane, Beside Lakshmikanth Theatre, Gajuwaka, Visakhapatnam, Andhra Pradesh, 530026.

When was Gajuwaka Pharmaceuticals Private Limited incorporated?

Gajuwaka Pharmaceuticals Private Limited was incorporated on 10 January 2002.

Who are the current directors of Gajuwaka Pharmaceuticals Private Limited?

The current directors of Gajuwaka Pharmaceuticals Private Limited are

What is the primary industry of Gajuwaka Pharmaceuticals Private Limited?

The primary industry of Gajuwaka Pharmaceuticals Private Limited is Trade.

Is Gajuwaka Pharmaceuticals Private Limited a listed company?

Gajuwaka Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Gajuwaka Pharmaceuticals Private Limited?

The authorized capital of Gajuwaka Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹1.88 M.

What is the compliance status of Gajuwaka Pharmaceuticals Private Limited?

The compliance status of Gajuwaka Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available